Clinical TrialsSearch results
Number of results: 386
Other
- Optimal combination of pharmacological agents for cardiovascular and renal complications of diabetes mellitus and impaired glucose tolerance
- Cardiovascular and renal complications of diabetes mellitus and impaired glucose tolerance
- Kyoto Medical Centar
- 2009-04-01
Other
- Phase II study of carboplatin-gemcitabine combination chemotherapy in elderly patients with advanced non–small cell lung cancer
- non small cell lung cancer
- Kumamoto University School of Medicine
- 2005-09-04
Other
- Prognostic value of CD144 positive endothelium-derived-microparticles (CD144-EMP) in patients with heart failure
- Japanese patinets with heart failure
- Kumamoto University Hospital
- 2009-07-30
Other
- The study for surgical outcome of trabeculectomy for neovascular glaucomatous patients who received bevacizumab treatment before the surgery.
- Patients with neovascular glaucoma
- Kumamoto University
- 2008-05-05
Other
- The study for surgical outcome of trabeculectomy for neovascular glaucomatous patients who received an additional bevacizumab treatment after the surgery.
- Patients with neovascular glaucoma
- Kumamoto University
- 2007-11-19
Other
- The efficacy and safety of Mild Electric current and Thermo (MET) in healthy human subjects.
- healthy males
- Kumamoto University
- 2008-08-26
Other
- Surgical outcome of trabeculectomy: phakia versus pseudophakia
- Patients with primary open-angle glaucoma, or patients with exfoliation glaucoma.
- Kumamoto University
- 2008-06-18
Other
- Intraocular pressure lowering effect of latanoprost for glaucomatous patients with trabeculectomy
- Patients with open-angle glaucoma after trabeculectomy
- Kumamoto University
- 2007-11-15
Other
- Importance of checking exon skipping events prior to clinical trials using systemically delivered antisense morpholino in Duchenne muscular dystrophy patients
- Duchenne muscular dystrophy
- Kumamoto University
- 2009-06-01
Other
- Safety and efficacy of Alternating mFOLFOX6 plus bevacizumab and FOLFIRI plus bevacizumab every 4cycles as First line Therapy in Advanced colorectal Cancer
- Unresectable advanced/recurrent colorectal cancer
- KSCC
- 2008-08-12